Blinded Study Medication-Johns Hopkins University

Blinded Study Medication-Johns Hopkins University refers to a group of oral medications used in the clinical trial Measuring Acute Drug Demand in Humans II (NCT05443490). This research, conducted by Johns Hopkins University, evaluates the acute effects of various drug classes on mood, pain, and cognitive performance in healthy volunteers. The study utilizes a double-blind, crossover design where participants receive different conditions containing FDA-approved medications used for non-FDA approved research purposes. These medications include prescription stimulants, cannabinoids, benzodiazepines, opioids, sleep medications, and over-the-counter drugs. The specific identities of the drugs are withheld to maintain the integrity of the blinding process and are intended to be disclosed upon the completion of the study.